The Use of Next-Generation Sequencing in Treating Non-Squamous Non-Small-Cell Lung CancerVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Goeffrey Oxnard and Lauren Ritterhouse consider how next-generation sequencing (NGS) informs treatment of lung cancer patients in providing information on tumor mutational burden, microsatellite instability, unique targetable genomic signatures, as well as novel targets that may be best addressed in a clinical trial.
Description: Dr. Boccia describes cases in which he uses CancerTREATMENT NGS+ in his clinical practice.
Dr Wainberg and Dr Gerson review why providers are using combination therapies and the eventual goal of investigators to hit specific targeted cells.